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Abstract
Background. Total hip replacement is a common orthopaedic procedure associated with an elevated cardiovascular 
risk. There are several methods for total hip replacement, including whether or not to use cement for the prosthesis 
fixation. The aim of the study was to compare clinical characteristics, including blood pressure, in patients under-
going total hip replacement with and without the use of cement.
Material and methods. The study included patients with elective total hip replacement surgery, who were divided 
into those in whom the procedure was performed with or without the use of medical cement. The criteria for using 
cement were assessed during operation by the operator, according to the current protocol. All patients were inter-
viewed, screened, and had their medical records checked for the prior diagnosis of cardiovascular risk factors. Blood 
pressure values were measured before and after the procedure according to the current guidelines.
Results. The study population consisted of 65 patients in whom the total hip replacement was performed (mean 
age 61.5 ± 15.0 years; 50.8% male). 60% of patients had the hip replacement without cement and 40.0% had  
a procedure with the use of cement. Patients in whom the cement was used were significantly older (75.0 ± 8.5 vs. 
53.0 ± 11.5 years; p < 0.0001) and more often diagnosed with arterial hypertension (61.5 vs. 33.3%; p = 0.04), than 
those in whom it was not used. Systolic blood pressure values were significantly higher before and after the procedure 
(138.8 ± 18.2 vs. 130.8 ± 21.5 mm Hg, p = 0.04; 122.6 ± 13.3 vs. 113.8 ± 14.1 mm Hg, p = 0.03; respectively) in 
the group which required cement. 
Conclusions: Patients with hip replacement using cement have higher systolic values before, and after the surgery 
than in patients in whom cement wasn’t used. Therefore careful management and risk assessment is especially im-
portant in patients receiving the total hip replacement with the use of cement.
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Introduction
Total hip replacement is the most common pro-
cedure in orthopaedic surgery. All orthopaedic pro-
cedures are major surgery procedure associated with 
perioperative risk [1, 2]. Proper perioperative car-
diovascular risk assessment and management is es-
pecially important, because of the high comorbidity 
rate in total hip replacement patients [3]. There are 
several methods for total hip replacement. The main 
distinguisher is the use of cement for the prosthesis. 
Techniques with cement are preferred when the bone 
structure has the slower metabolism and is weaker in 
structure. Based on data from the Polish National 
Health Fund (Narodowy Fundusz Zdrowia, NFZ) 
registry during the year 2013, younger patients 
had mainly non-cemented prosthesis implantation 
whereas in the group of patients above 80 years of 
age the number of cement implants was double the 
number of non-cement prostheses [4]. The aim of 
the study was to compare clinical characteristics, es-
pecially blood pressure values in patients undergoing 
total hip replacement with and without the use of 
cement.
Material and methods
The study was performed with respect to the De-
claration of Helsinki and an approval from the Ethics 
Committee by the Medical University of Warsaw was 
obtained before the beginning of the study. Every 
study participant gave a written informed consent 
prior to the study enrolment.
Study population
In the study, we enrolled patients who underwent 
elective total hip replacement surgery. All patients 
were qualified for the surgery prior to the study 
beginning. Exclusion criteria were: age < 18 or ≥ 
75 years, disqualification from the operation, the 
absence of written informed consent or contrain-
dications for any of the study protocol examina-
tions. Subsequent patients were divided into those in 
whom the procedure was performed with or without 
the use of medical cement. The criteria for using ce-
ment were assessed during operation by the operator, 
according to the current protocol. Investigators had 
no impact on the kind of procedure that was used. 
Diagnosis of cardiovascular risk factors and 
blood pressure
All patients were interviewed, screened, and had 
their medical records checked for the prior diagnosis 
of cardiovascular risk factors. Diagnosis of the con-
dition was made according to the current guidelines. 
For example, diagnosis of arterial hypertension was 
made when office blood pressure was equal or ex-
ceeded the values of 140 for systolic blood pressure 
(SBP) and/or 90 mm Hg for diastolic blood pressure 
(DBP), and/or patient had eligible medical records 
proofing the previous diagnosis, and/or patient was 
currently taking medications used for hypertension 
treatment. All study participants were screened for 
arterial hypertension. Patients had their blood pres-
sure measured on admission and after the procedure 
by a qualified physician. The number of required 
measurements, measure techniques and settings were 
in accordance with the current guidelines for arterial 
hypertension diagnosis and management of the Eu-
ropean Society of Cardiology and European Society 
of Hypertension [5].
Blood samples were obtained from all study par-
ticipants on admission from the cubital vein. Blood 
was drawn after the standard night-time fasting. All 
laboratory parameters were immediately assessed in 
the blood samples according to the current standard 
in the Hospital Laboratory.
Statistical analysis
Statistical analysis was performed using the SPSS 
v 21.0 (SPSS Inc, Chicago, IL, USA). Continuous 
data are presented as mean ± standard deviation (SD) 
and were compared using the Mann-Whitney test or 
Student’s t-test. Categorical variables were compared 
using either the c2 or Fisher’s exact tests. A p value of 
less than 0.05 was considered statistically significant, 
whereas the confidence intervals (CI) were 95%.
Results
The study population consisted of 65 patients in 
whom the total hip replacement was performed. The 
mean age of the study population was 61.5 ± 15.0 
years and 50.8% of patients were male. The cardio-
vascular risk factor with the highest prevalence in the 
study population was arterial hypertension observed 
in 44.6% of cases. 9.2% of patients had diabetes 
mellitus, 6.3% had coronary artery disease and 4.6% 
had diagnosed heart failure. Detailed characteristics 
of the study population can be found in Table I.
After dividing patients according to the procedure 
type we found that there we 39 (60.0%) patients 
with the hip replacement without cement and 26 
(40.0%) had a procedure with the use of cement. 
Patients in whom the cement was used were sig-
nificantly older (75.0 ± 8.5 vs. 53.0 ± 11.5 years; 
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requiring cement during procedure had significantly 
higher systolic blood pressure values before and after 
the procedure (138.8 ± 18.2 vs. 130.8 ± 21.5 mm Hg, 
p = 0.04; 122.6 ± 13.3 vs. 113.8 ± 14.1 mm Hg, 
p = 0.03; respectively) (Figure 1).
Several, significant differences were also found in 
the results of laboratory analysis and covered hae-
moglobin concentration, haematocrit, and urea and 
creatinine concentration. Details can be found in 
Table II.
Discussion
The discovery and production of medical cement 
date back to the year 1902. In this period, Otto 
Rohm introduced a method of polymerization of 
acrylic acid and production of cement (polymethyl 
methacrylate — PMMA). In the year 1936, industri-
al production of PMMA began. In that time medical 
cement was used to fill skull defects/gaps in animals 
(1939) as well as humans (1940) and in dentistry. 
During the Second World War, neurosurgeons start-
ed using PMMA during cranioplasty [6–8]. In the 
following years, indications for cement use began to 
expand. In orthopaedic surgery, bone cement is in 
use for over 50 years. It is applied in joint replace-
ment surgery (mainly hip, knee, and shoulder) as 
a fixing agent of the prosthesis with bone but also en-
ables filling of lost bone tissue secondary to removed 
cancer and in compression fractures of the vertebrae 
(vertebroplasty). It often supports and supplements 
other methods of stabilizing a fracture. In arthroplas-
ties, bone cement can contain antibiotics reducing the 
number of post-surgery infections [9]. Bone cement 
functions by transferring and evenly distributing any 
load applied to the bone [10]. In recent years, there 
Table I. Baseline characteristics of the study population 
Parameter Value  
(% or mean ± SD)
Age (years) 61.8 ± 15.0
Male sex 33 (50.8%)
Heart failure 3 (4.6%)
Diabetes mellitus 6 (9.2%)
Prior stroke or TIA 2 (3.1%)
Prior myocardial infarction 1 (1.6%)
Peripheral artery disease 1 (1.6%)
Smoking 1 (1.6%)
Dyslipidaemia 1 (1.6%)
Coronary artery disease 4 (6.3%)
Asthma or COPD 1 (1.6%)
Height [cm] 166.2 ± 22.6
Weight [kg] 76.3 ± 12.5
Blood pressure parameters
Previously diagnosed arterial hypertension 29 (44.6%)
SBP on admission [mm Hg] 134.3 ± 20.3
DBP on admission [mm Hg] 76.3 ± 15.4
HR on admission (beats per minute) 72.3 ± 12.6
SBP after surgery [mm Hg] 117.6 ± 14.3
DBP after surgery [mm Hg] 66.6 ± 10.6
HR after surgery (beats per minute) 69.2 ± 12.9
Laboratory results
White blood cells 7.9 ± 3.2
Red blood cells 4.4 ± 0.6
Haemoglobin 132.5 ± 18.5
Haematocrit (%) 40.0 ± 5.2
Mean cell volume 91.4 ± 5.6
MCHC 326.4 ± 40.3
Platelets 239.7 ± 68.4
Sodium 140.5 ± 3.1
Potassium 4.2 ± 0.4
Glucose 101.1 ± 22
Urea 37.3 ± 18.8
Creatinine 1.0 ± 0.4
INR 1.0 ± 0.1
APTT 30.1 ± 3.1
COPD — chronic, obstructive pulmonary disease, DBP — diastolic blood pressure, HR — heart rate, 
SBP — systolic blood pressure, SD — standard deviation, TIA — transient ischaemic attack
Data are presented as number (%) or mean ± SD
p < 0.0001) than those in whom it was not used. 
They were also more often diagnosed with arterial 
hypertension (61.5 vs. 33.3%; p = 0.04) and pre-
valence of heart failure was on the edge of statistical 
significance (11.5 vs. 0.0%; p = 0.06). When we 
analysed blood pressure values we found that patients 
Figure 1. Differences in blood pressure values in patients with and 
without the use of cement in hip replacement
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is the debate on the potential for bone cement to 
cause harm to patients and benefits of non-cemented 
arthroplasties are being raised. However, considering 
a certain cohort of patients, fixation of the prosthesis 
using bone cement still plays a crucial role in achiev-
ing satisfactory results after surgery. Examples of total 
hip replacement with or without cement are shown in 
Figures 2 and 3, respectively.
Currently, indications and advantages of the ce-
ment use can be summarized as follows:
—  cement is mostly indicated in older patients 
(more than 75 years), but are also used in younger 
Table II. Differences between patients undergoing hip replacement with or without cement
Parameter Patients with hip replacement 
without cement (n = 39)
Patients with hip replacement with 
cement (n = 26)
p value
Age (years) 53.0 ± 11.5 75.0 ± 8.5 < 0.0001
Male sex 22 (56.4%) 11 (42.3%) 0.32
Heart failure 0 (0.0%) 3 (11.5%) 0.06
Diabetes mellitus 3 (7.7%) 3 (11.5%) 0.45
Prior stroke or TIA 1 (2.6%) 1 (4.0%) 1.00
Prior myocardial infarction 1 (2.6%) 0 (0.0%) 1.00
Peripheral artery disease 0 (0.0%) 1 (4.2%) 0.38
Smoking 1 (2.6%) 0 (0.0%) 1.00
Dyslipidaemia 1 (2.6%) 0 (0.0%) 1.00
Coronary artery disease 1 (2.6%) 3 (11.5%) 0.29
Asthma or COPD 0 (0.0%) 1 (4.2%) 0.40
Height [cm] 166.3 ± 2.9 166.1 ± 8.2 0.19
Weight [kg] 76.9 ± 14.5 75.4 ± 9.1 0.93
Blood pressure parameters
Previously diagnosed arterial hypertension 13 (33.3%) 16 (61.5%) 0.04
SBP on admission [mm Hg] 130.8 ± 21.5 138.8 ± 18.2 0.04
DBP on admission [mm Hg] 75.0 ± 16.7 78.0 ± 13.6 0.25
HR on admission (beats per minute) 72.4 ± 13.2 72.0 ± 12.0 0.95
SBP after surgery [mm Hg] 113.8 ± 14.1 122.6 ± 13.3 0.03
DBP after surgery [mm Hg] 66.8 ± 11.5 66.2 ± 9.5 0.96
HR after surgery (beats per minute) 70.2 ± 14.0 67.8 ± 11.4 0.82
Laboratory results
White blood cells 7.5 ± 2.4 8.5 ± 4.0 0.39
Red blood cells 4.5 ± 0.7 4.3 ± 0.4 0.15
Haemoglobin 136.8 ± 20.1 126.2 ± 14.1 0.03
Haematocrit (%) 41.0 ± 5.7 38.4 ± 4.1 0.04
Mean cell volume 92.4 ± 6.3 90.0 ± 4.0 0.33
MCHC 333.4 ± 8.8 316.4 ± 61.4 0.03
Platelets 246.2 ± 73.3 230.3 ± 61.1 0.54
Sodium 139.8 ± 2.9 141.4 ± 3.2 0.08
Potassium 4.2 ± 0.4 4.2 ± 0.4 0.75
Glucose 100.6 ± 23.6 102.0 ± 19.7 0.45
Urea 34.0 ± 19.9 41.9 ± 16.5 0.01
Creatinine 1.0 ± 0.4 1.1 ± 0.3 0.06
INR 1.0 ± 0.1 1.0 ± 0.1 0.33
APTT 30.1 ± 3.3 30.1 ± 2.9 0.85
COPD — chronic, obstructive pulmonary disease, DBP — diastolic blood pressure, HR — heart rate, SBP — systolic blood pressure, SD — standard deviation, TIA — transient ischaemic attack 
Data are presented as number (%) or mean ± SD
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patients since there are some indications that ce-
mented stems are less prone to develop osteolysis;
—  useful for patients with “stove pipe” type femur, 
previous fracture, or previous osteotomy since 
these patients would not be expected to achieve 
a tight fit which is necessary for ingrowth; 
—  may be indicated by conditions resulting in poor 
bone quality such as rheumatoid arthritis, osteo-
porosis, or Paget’s disease; 
—  due to physical properties, and strong effect of 
stem size on the cement strains suggests that 
cemented femoral stems should not be used in 
heavy patients with small medullary canals that 
require a small cemented stem.
Bone cement in total hip replacement has several 
advantages that include: easier affixing of the pros-
thetic joint components to a bone that is slightly 
porous from osteoporosis, or a possibility to add 
a small amount of antibiotic material to the bone 
cement, helping to decrease the risk of post-surgical 
infection. However, drawbacks of this method also 
exist. A breakdown of the cement can cause the artifi-
cial joint to come loose, which may prompt the need 
for another joint replacement surgery (revision sur-
gery). The cement debris can irritate the surrounding 
soft tissue and cause inflammation. While rare, the 
cement can enter the bloodstream and end up in the 
lungs, a condition that can be life-threatening. There 
is also a complication called bone cement implanta-
tion syndrome (BCIS). It is characterized by episodes 
of hypoxia and/or hypotension with or without loss 
of consciousness correlated in time with bone cement 
application, prosthesis fixation, joint reduction or 
deflation of tourniquet during cement arthroplasty. 
It is linked with perioperative morbidity and mortal-
ity. The highest risk is related with hip arthroplasty 
and it is lower in knee arthroplasty and vertebroplas-
ty [11]. The incidence of BCIS is not known as there 
is no universal definition of the syndrome. According 
to available data based on non-uniform definitions of 
BCIS, the occurrence of the syndrome is estimated to 
occur in about 20% of cases and mortality secondary 
to BCIS is about 0.1% [12]. 
In our study, we showed that in patients, in whom 
the use of cement during total hip replacement was 
necessary, the SBP values were significantly high-
er before and after the surgery than in patients in 
whom the cement wasn’t used. Prevalence of arterial 
hypertension was also higher in patients in whom 
the cement was used. These findings are partially 
attributable to the higher mean age of the group with 
cement use. However, we must also keep in mind 
that patients with the use of cement had significant-
ly lower haemoglobin concentration, haematocrit, 
MCHC, and significantly higher urea and creatinine 
levels. Those factors, even despite the older age of pa-
tients are risk factors for perioperative complications 
in hip replacement. It was recently shown that SBP 
values in the perioperative period are the good pre-
dictor of myocardial injury after surgery [13]. While 
Figure 3. An example of a hip X-ray in an 80-year-old female with hip 
replacement using cement
Figure 2. An example of a hip X-ray in a 55-year-old male with non- 
-cement hip replacement
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hip replacement patients are at high cardiovascular 
risk [14], it is important to remember that careful 
management and risk stratification is important in 
this group, also considering the risk of BCIS.
In conclusion, patients with hip replacement us-
ing cement have higher SBP values before, and after 
the surgery than patients in whom cement wasn’t 
used. These patients are also at higher cardiovascular 
risk, therefore careful management and risk assess-
ment is especially important in patients receiving the 
total hip replacement with the use of cement. 
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